Moderna vaccine found '100% effective in preventing severe COVID-19 cases', Emergency use authorisation sought from FDA
Image Credit: Shortpedia
Moderna Inc, which is developing an mRNA-based vaccine against coronavirus, said its final set of trial data showed "100% effectiveness" in preventing severe cases of COVID-19. Earlier, the company had reported an overall efficacy rate of 94.1%. With this overwhelming success rate, Moderna has submitted its request before the US FDA, seeking emergency use authorisation at the earliest.